Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Fink

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
NPJ Vaccines|January 20, 2024
The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
NPJ Vaccines|December 9, 2024
Publisher Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
Journal of Virology|August 17, 2018
Using a Virion Assembly-Defective Dengue Virus as a Vaccine ApproachChao Shan, Xuping Xie, Jing Zou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responsesTobias Junt, Katja Fink, Reinhold Förster, et al.
FEBS Letters|August 2, 2019
Structure-guided design of immunomodulatory RNAs specifically targeting the cytoplasmic viral RNA sensor RIG-IHui Yee Yong, Jie Zheng, Victor Chin Yong Ho, et al.
Frontiers in Immunology|August 13, 2019
A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte SubsetsSiew-Min Ong, Karen Teng, Evan Newell, et al.
Antiviral Research|July 10, 2019
Altered monocyte response to the dengue virus in those with varying severity of past dengue infectionAchala Kamaladasa, Laksiri Gomes, Ayesha Wijesinghe, et al.
Vaccine|February 10, 2015
Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in miceRoland Zuest, Iris Valdes, David Skibinski, et al.
Nature|July 14, 2020
A perspective on potential antibody-dependent enhancement of SARS-CoV-2Ann M Arvin, Katja Fink, Michael A Schmid, et al.
European Journal of Immunology|July 1, 2006
Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responsesKatja Fink, Karl S Lang, Nataly Manjarrez-Orduno, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
NPJ Vaccines|January 20, 2024
The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
NPJ Vaccines|December 9, 2024
Publisher Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
Journal of Virology|August 17, 2018
Using a Virion Assembly-Defective Dengue Virus as a Vaccine ApproachChao Shan, Xuping Xie, Jing Zou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responsesTobias Junt, Katja Fink, Reinhold Förster, et al.
FEBS Letters|August 2, 2019
Structure-guided design of immunomodulatory RNAs specifically targeting the cytoplasmic viral RNA sensor RIG-IHui Yee Yong, Jie Zheng, Victor Chin Yong Ho, et al.
Frontiers in Immunology|August 13, 2019
A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte SubsetsSiew-Min Ong, Karen Teng, Evan Newell, et al.
Antiviral Research|July 10, 2019
Altered monocyte response to the dengue virus in those with varying severity of past dengue infectionAchala Kamaladasa, Laksiri Gomes, Ayesha Wijesinghe, et al.
Vaccine|February 10, 2015
Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in miceRoland Zuest, Iris Valdes, David Skibinski, et al.
Nature|July 14, 2020
A perspective on potential antibody-dependent enhancement of SARS-CoV-2Ann M Arvin, Katja Fink, Michael A Schmid, et al.
European Journal of Immunology|July 1, 2006
Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responsesKatja Fink, Karl S Lang, Nataly Manjarrez-Orduno, et al.
Pageof 9